Results 191 to 200 of about 53,087 (243)

Targeting mitochondrial quality control in diabetic kidney disease: emerging therapeutic opportunities. [PDF]

Ren Fail
Luo J, Lu F, Cuciureanu M, Xu X, Dong H, Gong M.   +5 more
europepmc   +1 more source

Targeting High-Density Aromatic Peptides to Cardiolipin Optimizes the Mitochondrial Membrane Potential and Inhibits Oxidative Stress. [PDF]

FASEB Bioadv
Birk A, Arain S, Musumeci D, Garcia-Marin V, MacNeil MA.   +4 more
europepmc   +1 more source

Protocol for isolation of lipid droplets and mitochondria from acute myeloid leukemia cells for lipidomic analysis. [PDF]

STAR Protoc
Zhao R, Zhang L, Dong S, Kamachi K, Gupta SK, Akiyama H, Nguyen J, Hackman GL, Andreeff M, Lodi A, Ishizawa J.   +10 more
europepmc   +1 more source

Anti-Cardiolipin-Antikörper [PDF]

, 2019
openaire   +1 more source

An Unusual Complication at an Unusual Site: Internal Jugular Vein Thrombosis Revealing Celiac Disease. [PDF]

Cureus
Mouharir M, Chahbi Z, Qacif H, Kaddouri S, Zyani M.   +4 more
europepmc   +1 more source

CARDIOLIPIN antigens.

Bulletin of the World Health Organization, 2004
openaire   +1 more source

GV1001, an hTERT-Derived Peptide, Prevents Cisplatin-Induced Nephrotoxicity by Preserving Mitochondrial Function. [PDF]

Cells
Chen W, Beheshtian C, Kim S, Kim R, Kim S, Park NH.   +5 more
europepmc   +1 more source

Development of Mitochondria-Targeted PARP Inhibitors. [PDF]

Biomolecules
Dimitrijevs P, Makrecka-Kuka M, Arsenyan P.   +2 more
europepmc   +1 more source

Antibodies to Periodontal Bacteria Are Associated with Systemic Lupus Erythematosus and Autoantibody Positivity. [PDF]

Int J Mol Sci
Massarenti L, Leffers HCB, Brodersen T, Hansen PR, Damgaard C, Pedersen OB, Jacobsen S, Nielsen CH.   +7 more
europepmc   +1 more source